Continuous monitoring ‘detects AF but fails to reduce stroke’
Use of an implantable monitor in high-risk patients disappoints in randomised trial, researchers find
Tag: ESC Congress 2021
New evidence favours intensive BP lowering in the elderly
A large Chinese study backs the landmark SPRINT trial findings, researchers say.
Finerenone cuts CV risk in patients with diabetes and kidney disease
The new agent reduces hospitalisation for heart failure and renal disease progression, research shows.
‘Lay responders’ boost cardiac arrest survival: study
Use of a mobile app means patients are more likely to receive timely CPR or defibrillation, researchers show.
Novel ‘quadpill’ for lowering BP trumps standard monotherapy: Aus trial
Researchers report on the QUARTET study of quarter-doses of four antihypertensives in one capsule
Polypill with aspirin ‘preferred for CVD prevention’
Whether polypills include aspirin or not, they will be a key strategy for primary prevention, researcher says.
Therapeutic heparin dose ‘reduces clotting risk’ for patients with COVID-19
A US trial is the first to show such a benefit in patients at high risk of thrombosis.
Salt substitute cuts stroke risk, study shows
One of the largest dietary intervention studies ever conducted finds sodium-reduced condiment reduces cardiovascular deaths.
Gene-silencing to curb LDL-C ‘could dramatically cut CVD risk’
Researchers have attempted to simulate a 50-year randomised controlled trial.
‘Safe to delay’ angiogram in cardiac arrest survivors without ST elevation
Trial shows there is no mortality benefit of an immediate visit to the cath lab.
